# Treatment of Early Knee Osteoarthritis With Autologous Adipose-derived Mesenchymal Stem Cells

> **NCT03956719** · NA · UNKNOWN · sponsor: **Qilu Hospital of Shandong University** · enrollment: 8 (estimated)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **DRUG:** Autologous adipose-derived mesenchymal stem cells
- **PROCEDURE:** abdominal liposuction

## Key facts

- **NCT ID:** NCT03956719
- **Lead sponsor:** Qilu Hospital of Shandong University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03-02
- **Primary completion:** 2020-09-09
- **Final completion:** 2020-11-01
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2020-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03956719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03956719, "Treatment of Early Knee Osteoarthritis With Autologous Adipose-derived Mesenchymal Stem Cells". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03956719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*